RE:RE:RE:RE:RE:RE:RE:BullishSandblaster1980 wrote: Sandblaster1980 wrote: TheeRook wrote: FDA EUA has a low bar of 80% so I think that is already priced in with the last run to $10 , based on the MRI lab tests. .
The Nasdaq application too priced in too kept the share price from falling too far below $7.
Only thing is if larger orders start coming in. Which after some sucessful trial runs should start coming in after FDA EUA approval.
There are 100 hundreds of test out there the best current ones (PCR, Molecular testing) take time to do for 100% accuracy. Newer leading edge tech take 45minutes for a 100% test.
SONA at present 96% is a good fast screen based on lab tests that needs to be followed up with a more accurate test. according to guidlines So SONA has some work to do to bring it up to 100%... Some may think 96% is good but that means 4 out of 100 could be flase negative and beocme spreaders. Does not take many to spread Covid 19 as what is happening now in the US.
willywonka wrote: As a cautious investor, there are two positives that I consider. 1) Awaiting approval of tests 2) application to NASDAQ. If these work out then watch out
That true 4 people out of a 100 could test negative and actually have the virus. Assuming you are tested 1 time. Could they not test you twice to see if you have covid? JMHO. Glta
If you test positive for covid 19 then they know you need to be isolated, if you test negative then maybe a retest to confirm those results. I don't know if this will work but seems reasonable to me.